相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Characterization of Microsomal Prostaglandin E Synthase 1 Inhibitors
Marina Korotkova et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts
X. Wang et al.
BRITISH JOURNAL OF CANCER (2013)
Re: Cox-2 Inhibition Enhances the Activity of Sunitinib in Human Renal Cell Carcinoma Xenografts
Anthony Atala
JOURNAL OF UROLOGY (2013)
Comprehensivemolecular characterization of clear cell renal cell carcinoma
Chad J. Creighton et al.
NATURE (2013)
PGE2 promotes renal carcinoma cell invasion through activated RalA
Z. Li et al.
ONCOGENE (2013)
E-type prostanoid receptor 4 (EP4) in disease and therapy
Viktoria Konya et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Targeting angiogenesis in the pathological ovary
W. Colin Duncan et al.
REPRODUCTION FERTILITY AND DEVELOPMENT (2013)
Multifaceted roles of PGE2 in inflammation and cancer
Masako Nakanishi et al.
SEMINARS IN IMMUNOPATHOLOGY (2013)
Concurrent targeting of eicosanoid receptor 1/eicosanoid receptor 4 receptors and COX-2 induces synergistic apoptosis in Kaposi's sarcoma-associated herpesvirus and Epstein-Barr virus associated non-Hodgkin lymphoma cell lines
Arun George Paul et al.
TRANSLATIONAL RESEARCH (2013)
Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies
Arun George Paul et al.
TRANSLATIONAL RESEARCH (2013)
Adjuvant and neoadjuvant therapy for renal cell carcinoma: A survey of the Society of Urologic Oncology
Conrad M. Tobert et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)
Myeloid suppressor cells and immune modulation in lung cancer
Minu K. Srivastava et al.
IMMUNOTHERAPY (2012)
Interferon-Gamma-Induced Nitric Oxide Inhibits the Proliferation of Murine Renal Cell Carcinoma Cells
David J. Tate et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Cyclooxygenase-2 Expression and Its Prognostic Significance in Clear Cell Renal Cell Carcinoma
Ji Won Lee et al.
KOREAN JOURNAL OF PATHOLOGY (2012)
Prostanoids in tumor angiogenesis: therapeutic intervention beyond COX-2
M. Dolores Salvado et al.
TRENDS IN MOLECULAR MEDICINE (2012)
The role of the EP receptors for prostaglandin E2 in skin and skin cancer
J. E. Rundhaug et al.
CANCER AND METASTASIS REVIEWS (2011)
Biology of Cox-2: An Application in Cancer Therapeutics
Zakir Khan et al.
CURRENT DRUG TARGETS (2011)
Prostaglandin E2 Regulates Renal Cell Carcinoma Invasion through the EP4 Receptor-Rap GTPase Signal Transduction Pathway
Juanjuan Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Protein Kinase CK2 Promotes Cancer Cell Viability Via Up-Regulation of Cyclooxygenase-2 Expression and Enhanced Prostaglandin E2 Production
Roger Yefi et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Clinical and Immunomodulatory Effects of Celecoxib Plus Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients with COX-2 Tumor Immunostaining
Anita Schwandt et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Stroke risk and NSAIDs: a systematic review of observational studies
Cristina Varas-Lorenzo et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2011)
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
Sven Trelle et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma
Michel Choueiri et al.
CURRENT CLINICAL PHARMACOLOGY (2011)
Toxicity of Sunitinib Plus Bevacizumab in Renal Cell Carcinoma
Brian I. Rini et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
EP1 Prostanoid Receptor Coupling to Gi/o Up-Regulates the Expression of Hypoxia-Inducible Factor-1α through Activation of a Phosphoinositide-3 Kinase Signaling Pathway
Ruyue Ji et al.
MOLECULAR PHARMACOLOGY (2010)
Enhancement of the Sensitivity of Renal Cell Carcinoma Cells to Fas-Mediated Cytotoxicity and Apoptosis by the Selective Cyclooxygenase-2 Inhibitor JTE-522
Nodoka Sato et al.
UROLOGIA INTERNATIONALIS (2010)
Molecular biomarkers for advanced renal cell carcinoma: Implications for prognosis and therapy
Hyo Song Kim et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2010)
The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma
Jin F. Li et al.
BJU INTERNATIONAL (2009)
Cancer Statistics, 2009
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Combination Targeted Therapy in Advanced Renal Cell Carcinoma
Jeffrey Sosman et al.
CANCER (2009)
Multicenter Phase II Trial of Combination Therapy with Meloxicam, a COX-2 Inhibitor, and Natural Interferon-α for Metastatic Renal Cell Carcinoma
Nobuo Shinohara et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2009)
Physiological regulation of prostaglandins in the kidney
Chuan-Ming Hao et al.
ANNUAL REVIEW OF PHYSIOLOGY (2008)
Metastatic renal cell carcinoma: recent advances and current therapeutic options
Andres Jan Schrader et al.
ANTI-CANCER DRUGS (2008)
Adjuvant and neoadjuvant therapy in renal cell carcinoma
Eric Jonasch et al.
CANCER JOURNAL (2008)
Prevention of both direct and cross-priming of antitumor CD8+ T-Cell responses following overproduction of prostaglandin E2 by tumor cells in vivo
Maryam Ahmadi et al.
CANCER RESEARCH (2008)
VEGF, COX-2, and PCNA expression in renal cell carcinoma subtypes and their prognostic value
Ayhan Dirim et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2008)
Effect of arginase II on L-arginine depletion and cell growth in murine cell lines of renal cell carcinoma
David J. Tate et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2008)
The clinical application of COX-2 inhibitors may strengthen the sensitivity of renal cell carcinoma to immunotherapy
Jinfeng Li et al.
MEDICAL HYPOTHESES (2008)
Cyclooxygenase-2 expression: Does it have a probable role in tumorigenesis mechanisms of renal cell carcinoma?
Sinan Sozen et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2008)
Opportunities and obstacles to combination targeted therapy in renal cell cancer
Jeffrey A. Sosman et al.
CLINICAL CANCER RESEARCH (2007)
Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma
Augusto C. Ochoa et al.
CLINICAL CANCER RESEARCH (2007)
Targeting prostaglandin E EP receptors to inhibit metastasis
Amy M. Fulton et al.
CANCER RESEARCH (2006)
Expression of COX-2 in normal and pyelonephritic kidney, renal intraepithelial neoplasia, and renal cell carcinoma
M. Ugur Mungan et al.
EUROPEAN UROLOGY (2006)
Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival
J. James Bruno et al.
BJU INTERNATIONAL (2006)
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
PC Rodriguez et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Cyclooxygenase-2 and p53 expression as prognostic indicators in conventional renal cell carcinoma
DS Cho et al.
YONSEI MEDICAL JOURNAL (2005)
Cyclooxygenase-2 expression and relationship to tumour progression in human renal cell carcinoma
Y Hashimoto et al.
HISTOPATHOLOGY (2004)
Significance of COX-2 expression in human renal cell carcinoma cell lines
QZ Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Significance of COX-2 expression in human renal cell carcinoma
B Tuna et al.
UROLOGY (2004)
Mechanisms and functional significance of tumour-induced dendritic-cell defects
D Gabrilovich
NATURE REVIEWS IMMUNOLOGY (2004)
Cycloxygenase-2 is expressed in vasculature of normal and ischemic adult human kidney and is colocalized with vascular prostaglandin E2 EP4 receptors
KL Therland et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Renal cell carcinoma induces prostaglandin E2 and T-helper type 2 cytokine production in peripheral blood mononuclear cells
GP Smyth et al.
ANNALS OF SURGICAL ONCOLOGY (2003)
分享论文
